Purslane Portulaca oleracea L.
Purslane (Portulaca oleracea) is a succulent plant found worldwide, often as a weed in field crops and lawns, and eaten as a potherb in Europe, Asia and the Mediterranean region. Human trials have used purslane extracts and other purslane preparations.
- Category
- Botanical
- Part used
- Leaves and other aerial parts, eaten as food or used as extracts; several trials used the seeds
- Strongest evidence
- B Some positive trials
- Native range
- Native to Macaronesia, Africa and east-central and southern Europe to Pakistan and the Arabian Peninsula (POWO: "Macaronesia, Africa, EC. & S. Europe to Pakistan and Arabian Pen.")
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2023 systematic review and dose-response meta-analysis pooled 14 effect sizes from 13 RCTs of oral purslane alone (combinations excluded) versus control on lipids and C-reactive protein; a 2019 meta-analysis pooled six RCTs (352 participants). [3]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BBlood sugar and weight2 topics
CStomach and gut1 topic
CSkin and hair1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood lipids and C-reactive protein | B | A 2023 meta-analysis of 13 RCTs found lower triglycerides (-16.72 mg/dL), total cholesterol (-9.97 mg/dL) and CRP (-1.22 mg/L) and higher HDL (+4.09 mg/dL); LDL was not affected. [3] |
| Fasting glucose and insulin resistance | B | A 2023 meta-analysis of RCTs found purslane lowered fasting blood glucose (weighted mean difference -6.37) but had no significant effect on insulin, HOMA-IR or QUICKI; the authors called for higher-quality trials. [4] |
| Blood pressure and body weight | B | A 2023 meta-analysis of seven RCTs found lower body weight (-0.73 kg), BMI (-0.35 kg/m2) and systolic blood pressure (-3.64 mmHg), with no significant effect on waist circumference or diastolic pressure. [5] |
| Type 2 diabetes on one oral glucose-lowering drug | C | A 12-week placebo-controlled RCT (63 adults) of purslane extract found a larger systolic blood pressure drop (-7.5 vs -0.01 mmHg); HbA1c fell more only in a subgroup of responders. [6] |
| Functional constipation | C | An 8-week double-blind RCT in 60 patients found an ethanol extract of the aerial parts improved complete spontaneous bowel movements, symptoms and quality of life versus placebo. [7] |
| Chronic hand eczema (oral syrup) | C | A 4-week RCT in 70 adults found purslane syrup plus topical Vaseline lowered fissure, itching and dryness scores versus placebo syrup plus Vaseline. [8] |
Main constituents: Flavonoids, homoisoflavonoids, alkaloids, organic acids, esters, lignans, terpenoids, catecholamines, sterols and cerebrosides, plus omega-3 fatty acids, amino acids, minerals and vitamins [1]; Alpha-linolenic acid (omega-3), alpha-tocopherol and ascorbic acid; potassium 494 mg/100 g; leaf oxalate reported at 671–869 mg/100 g fresh weight [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Three capsules of purslane extract per day for 12 weeks (type 2 diabetes trial). [6]
- A 2023 dose-response meta-analysis states that, according to a suggested optimal dosage, purslane consumption is considered safe up to 30 g/day. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Case reports describe acute kidney injury from oxalate nephropathy after high dietary consumption of purslane; two elderly patients needed hemodialysis and were discharged after creatinine improved. [9]
- Purslane leaves contain 671–869 mg oxalate per 100 g fresh weight. [2]
- In the hand-eczema trial, mild to moderate adverse events occurred in 10 participants on purslane and 4 on placebo (p = 0.068). [8]
- In the 12-week diabetes trial, few adverse events were reported; they were mild and did not differ between groups. [6]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [10]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming purslane or Portulaca oleracea was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of purslane (Portulaca oleracea) was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-29). [P4]
- The NTP Technical Reports index (TR-001 to TR-606) lists no study of purslane or Portulaca (checked 2026-10-29). [P5]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P6]
- Oxalate content — Purslane leaves are reported to contain 671–869 mg oxalate per 100 g fresh weight. [P2]
Supply and conservation
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Li K, et al. A review on ethnopharmacology, phytochemistry, pharmacology and potential uses of Portulaca oleracea L. J Ethnopharmacol 2024;319(Pt 2):117211 (PMID 37739100), 2024-01. pubmed.ncbi.nlm.nih.gov
- Uddin MK, et al. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. ScientificWorldJournal 2014;2014:951019 (PMID 24683365), 2014-02. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Volumes 1–142 (retrieved 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; retrieved 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Portulaca oleracea L., 2026-10-29. api.gbif.org
Sources
- Li K, et al. A review on ethnopharmacology, phytochemistry, pharmacology and potential uses of Portulaca oleracea L. J Ethnopharmacol 2024;319(Pt 2):117211 (PMID 37739100), 2024-01. pubmed.ncbi.nlm.nih.gov
- Uddin MK, et al. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. ScientificWorldJournal 2014;2014:951019 (PMID 24683365), 2014-02. pubmed.ncbi.nlm.nih.gov
- Jafari N, et al. The effects of purslane consumption on lipid profile and C-reactive protein: a systematic review and dose-response meta-analysis. Food Sci Nutr 2023;11(11):6728-6748 (PMID 37970383), 2023-08. pubmed.ncbi.nlm.nih.gov
- Abbasi S, et al. The effects of purslane (Portulaca oleracea) on glycemic indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Phytother Res 2023;37(12):5529-5540 (PMID 37661794), 2023-12. pubmed.ncbi.nlm.nih.gov
- Narimani B, et al. The effects of purslane consumption on blood pressure, body weight, body mass index, and waist circumference: a systematic review and meta-analysis of randomised controlled trials. J Nutr Sci 2023;12:e129 (PMID 38155802), 2023-12. pubmed.ncbi.nlm.nih.gov
- Wainstein J, et al. Purslane extract and glucose homeostasis in adults with type 2 diabetes: a double-blind, placebo-controlled clinical trial of efficacy and safety. J Med Food 2016;19(2):133-140 (PMID 26854844), 2016-02. pubmed.ncbi.nlm.nih.gov
- Bang KB, et al. Effect of Portulaca oleracea L. extract on functional constipation: a randomized, double-blind, placebo-controlled trial. Saudi J Gastroenterol 2022;28(4):296-303 (PMID 35848700), 2022-07. pubmed.ncbi.nlm.nih.gov
- Heydarirad G, et al. Efficacy and safety of purslane (Portulaca oleracea) for mild to moderate chronic hand eczema: a randomized, double-blind, placebo-controlled clinical trial. Explore (NY) 2024;20(3):401-410 (PMID 37872023), 2024-05. pubmed.ncbi.nlm.nih.gov
- Wang X, et al. Purslane-induced oxalate nephropathy: case report and literature review. BMC Nephrol 2023;24(1):207 (PMID 37443012), 2023-07. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- Hadi A, et al. Effect of purslane on blood lipids and glucose: a systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019;33(1):3-12 (PMID 30281177), 2019-01. pubmed.ncbi.nlm.nih.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Portulaca oleracea L. (accessed 2026-10-29; native range: "Macaronesia, Africa, EC. & S. Europe to Pakistan and Arabian Pen."), 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.